Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-09
2008-07-01
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S236000
Reexamination Certificate
active
07393847
ABSTRACT:
The invention relates to substituted imidazopyridazinediones of general formulawherein R1and R4are defined as in claim 1, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
REFERENCES:
patent: 2928833 (1960-03-01), Leake et al.
patent: 4005208 (1977-01-01), Bender
patent: 4599338 (1986-07-01), Regnier et al.
patent: 5041448 (1991-08-01), Janssens
patent: 5051517 (1991-09-01), Findeisen
patent: 5223499 (1993-06-01), Greenlee
patent: 5234897 (1993-08-01), Findeisen et al.
patent: 5258380 (1993-11-01), Janssens
patent: 5266555 (1993-11-01), Findeisen et al.
patent: 5389642 (1995-02-01), Dorsch
patent: 5470579 (1995-11-01), Bonte et al.
patent: 5719279 (1998-02-01), Kufner-Muhl et al.
patent: 5753635 (1998-05-01), Buckman
patent: 6303661 (2001-10-01), Demuth
patent: 6342601 (2002-01-01), Bantick
patent: 6548481 (2003-04-01), Demuth et al.
patent: 6579868 (2003-06-01), Asano
patent: 6821978 (2004-11-01), Chackalamannil
patent: 6869947 (2005-03-01), Kanstrup
patent: 7060722 (2006-06-01), Kitajima
patent: 7074794 (2006-07-01), Kitajima
patent: 7074798 (2006-07-01), Yoshikawa
patent: 7074923 (2006-07-01), Dahanukar
patent: 7109192 (2006-09-01), Hauel
patent: 7179809 (2007-02-01), Eckhardt
patent: 7183280 (2007-02-01), Himmelsbach
patent: 7192952 (2007-03-01), Kanstrup
patent: 7217711 (2007-05-01), Eckhardt
patent: 7235538 (2007-06-01), Kanstrup et al.
patent: 2002/0161001 (2002-10-01), Kanstrup
patent: 2002/0169174 (2002-11-01), Chackalamannil et al.
patent: 2002/0198205 (2002-12-01), Himmelsbach
patent: 2003/0105077 (2003-06-01), Kanstrup et al.
patent: 2003/0199528 (2003-10-01), Kanstrup
patent: 2003/0232987 (2003-12-01), Dahanukar et al.
patent: 2003/0236272 (2003-12-01), Carr
patent: 2004/0034014 (2004-02-01), Kanstrup et al.
patent: 2004/0077645 (2004-04-01), Himmelsbach et al.
patent: 2004/0082570 (2004-04-01), Yoshikawa
patent: 2004/0087587 (2004-05-01), Himmelsbach
patent: 2004/0097510 (2004-05-01), Himmelsbach et al.
patent: 2004/0116328 (2004-06-01), Yoshikawa et al.
patent: 2004/0122228 (2004-06-01), Maier
patent: 2004/0138214 (2004-07-01), Himmelsbach et al.
patent: 2004/0138215 (2004-07-01), Eckhardt
patent: 2004/0166125 (2004-08-01), Himmelsbach
patent: 2005/0020574 (2005-01-01), Hauel et al.
patent: 2005/0026921 (2005-02-01), Eckhardt
patent: 2005/0130985 (2005-06-01), Himmelsbach
patent: 2005/0171093 (2005-08-01), Eckhardt et al.
patent: 2005/0187227 (2005-08-01), Himmelsbach et al.
patent: 2005/0203095 (2005-09-01), Eckhardt
patent: 2005/0234108 (2005-10-01), Himmelsbach et al.
patent: 2005/0261352 (2005-11-01), Eckhardt
patent: 2006/0004074 (2006-01-01), Eckhardt
patent: 2006/0058323 (2006-03-01), Eckhardt et al.
patent: 2006/0063787 (2006-03-01), Yoshikawa
patent: 2006/0079541 (2006-04-01), Langkopf
patent: 2006/0094722 (2006-05-01), Yasuda
patent: 2006/0142310 (2006-06-01), Pfrengle et al.
patent: 2006/0173056 (2006-08-01), Kitajima
patent: 2006/0205711 (2006-09-01), Himmelsbach
patent: 2006/0247226 (2006-11-01), Himmelsbach
patent: 2007/0027168 (2007-02-01), Pfrengle et al.
patent: 2007/0088038 (2007-04-01), Eckhardt
patent: 2007/0093659 (2007-04-01), Bonfanti
patent: 2007/0142383 (2007-06-01), Eckhardt
patent: 2136288 (1995-05-01), None
patent: 2418656 (2002-02-01), None
patent: 2496325 (2004-03-01), None
patent: 2496249 (2004-04-01), None
patent: 2505389 (2004-05-01), None
patent: 2508233 (2004-06-01), None
patent: 2529729 (2004-12-01), None
patent: 2540374 (2005-06-01), None
patent: 2555050 (2005-09-01), None
patent: 2556064 (2005-09-01), None
patent: 2590912 (2006-06-01), None
patent: 10109021 (2002-09-01), None
patent: 10117803 (2002-10-01), None
patent: 0149578 (1985-07-01), None
patent: 0400974 (1990-05-01), None
patent: 0399285 (1990-11-01), None
patent: 0412358 (1991-02-01), None
patent: 0524482 (1993-01-01), None
patent: 0657454 (1995-06-01), None
patent: 1054012 (2000-11-01), None
patent: 1338595 (2003-08-01), None
patent: 1 514 552 (2005-03-01), None
patent: 1537880 (2005-08-01), None
patent: 385302 (1973-04-01), None
patent: 2707641 (1995-01-01), None
patent: S37-4895 (1962-06-01), None
patent: 2003/300977 (2003-10-01), None
patent: 2006/045156 (2006-02-01), None
patent: 91/07945 (1991-06-01), None
patent: 94/03456 (1994-02-01), None
patent: 99/29695 (1999-06-01), None
patent: 2002/02560 (2002-01-01), None
patent: 200214271 (2002-02-01), None
patent: 2002/24698 (2002-03-01), None
patent: 2002/068420 (2002-09-01), None
patent: 2003/004496 (2003-01-01), None
patent: 2003/024965 (2003-03-01), None
patent: 2003/057200 (2003-07-01), None
patent: 2003/104229 (2003-12-01), None
patent: 2004/018467 (2004-03-01), None
patent: 2004/018468 (2004-03-01), None
patent: 2004/028524 (2004-04-01), None
patent: 2004/033455 (2004-04-01), None
patent: 2004/041820 (2004-05-01), None
patent: 2004/046148 (2004-06-01), None
patent: 2004/048379 (2004-06-01), None
patent: WO 2004/050658 (2004-06-01), None
patent: 2004/096806 (2004-11-01), None
patent: WO 2004/108730 (2004-12-01), None
patent: WO 2005/058901 (2005-06-01), None
patent: 2005/082906 (2005-09-01), None
patent: 2005/085246 (2005-09-01), None
patent: 2004/111051 (2005-12-01), None
patent: 2006/029769 (2006-03-01), None
patent: 2006/048427 (2006-05-01), None
patent: 2006/068163 (2006-06-01), None
patent: 2007/017423 (2007-02-01), None
Belijean-Leymarie et al., Hydrazines et hydrazones hétérocycliques. IV. Synthéses de dérivés de l'hydrazine dans la série des imidiazo[4,5-d]pyridazones-4, Can. J. Chem. 61, 2563 (1983).
U.S. Appl. No. 11/744700, filed May 4, 2007, Sieger.
U.S. Appl. No. 11/744701, filed May 4, 2007, Kohlrausch.
U.S. Appl. No. 11/744703, filed May 4, 2007, Dugi.
Augustyns, K. et al., The Unique Properties of Dipeptidyl-peptidase IV (DPP IV/CD 26) and the Therapeutic Potential of DPP-IV Inhibitors, Current Medicinal Chemistry, vol. 6, No. 4, 1999, pp. 311-327.
Bollag, R.J. et al; “Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors,” Endocrinology, vol. 141, No. 3, 2000, pp. 1228-1235.
Brittain, H.G., “Methods for the Characterization of Polymorphs: X-Ray Powder Diffraction,” Polymorphism in Pharmaceutical Solids, 1999, p. 235-238.
Busso et al., “Circulating CD26 is Negatively Associated with Inflammation in Human and Experimental Arthritis,” Am. J. Path., vol. 166, No. 2, Feb. 2005, pp. 433-442.
Caira, M.R., “Crystalline polymorphism of organic compounds” Topics in Current Chemistry, Springer, Berlin, vol. 198, 1998, p. 163-208.
Conarello, S.L. et al; “Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance,” PNAS 2003; 100: 6825-6830; originally published online May 14, 2003; information current as of Dec. 2006. www.pnas.org/cgi/content/full/100/11/6825.
Deacon, C.F. et al; “Dipeptidyl peptidase IV inhabitation as an approach to the treatment and prevention of type 2 diabetes: a historical perspective;” Biochemical and Biophysical Research Communications (BBRC) 294 (2002) 1-4.
DeMeester, I. et al.; “CD26, let it cut or cut it dowm”, Review: Immunology Today; Aug. 1999, vol. 20, No. 8 pp. 367-375.
Korom, S. et al; Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients1,2, Transplantation, May 27, 1997, vol. 63, No. 10, pp. 1495-1500.
Pospislik, et al; Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates β-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats; Diabetes, vol. 52, Mar. 2003 pp. 741-750.
Rhee et al.: “Nitrogen-15-Labeled Deoxynucleosides. 3. Synthesis of [3-15N]-2'-Deoxyadenosine” J. Am. Chem. Soc. 1990, 112, 8174-8175.
Sedo, A. et al; “Dipeptidyl peptidase IV activity and/or structure homologs: Contributing factors in the pathogenesis of rheumatoid arthritis?” Arthritis Research & The
Eckhardt Matthias
Himmelsbach Frank
Kauffmann-Hefner Iris
Langkopf Elke
Tadayyon Mohammad
Boehringer Ingleheim International GmbH
Devlin Mary-Ellen M.
Habte Kahsay
Morris Michael P.
LandOfFree
Imidazopyridazinediones, their preparation and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridazinediones, their preparation and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridazinediones, their preparation and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3974078